Cerebras Systems IPO: $3.5B Raise Targets a $28B Valuation
Cerebras Systems targets $3.5B in a May 14 Nasdaq IPO, riding 76% revenue growth and a $10B+ OpenAI compute deal to a valuation near $28 billion.
Follow initial public offerings and other public share offerings. Learn about pricing, share sales, dilution and listing mechanics, and distinguish announced plans from completed transactions. Find your way around ECMSource.
Cerebras Systems targets $3.5B in a May 14 Nasdaq IPO, riding 76% revenue growth and a $10B+ OpenAI compute deal to a valuation near $28 billion.
Fervo Energy prices its Nasdaq IPO this week at $21–$24/share, targeting a $6.5B valuation as AI data-center demand puts firm geothermal power in the spotlight.
HawkEye 360 (NYSE: HAWK) priced at $26, raising $416M. Revenue surged 74% to $118M and EBITDA turned positive as defense-tech satellite demand accelerates.
Cerebras Systems targets a $40B valuation in its IPO, backed by a landmark OpenAI deal and AWS Bedrock integration that transformed its revenue base.
Lincoln International filed an S-1 with the SEC to list on NYSE under ticker LCLN. With $783.8M in 2025 revenue and Goldman Sachs and Morgan Stanley as underwriters, here’s what it means for capital markets.
Bill Ackman’s Pershing Square raises $5B in a dual NYSE IPO but shares sink ~18% on debut as retail demand misses the original $25B target.
A plain-English guide to how companies go public — from the S-1 filing to bookbuilding, pricing night, and the greenshoe stabilization option.
Amazon-backed X-Energy raised $1.02B in its NASDAQ IPO on April 24, 2026, with shares surging 27%—the biggest nuclear startup listing in years.
SpaceX filed confidentially for an IPO targeting a $1.75 trillion valuation and late June 2026 debut. Here’s what the landmark deal means for capital markets.
The U.S. IPO market has completed 100 deals in 2026, running 6% ahead of last year’s pace. Biotech and defense tech are leading first-day pops. Here’s what’s fueling the rebound.